Trials / Completed
CompletedNCT01433952
Pharmacokinetics of Oral Thiamine
Pharmacokinetics of High Dose Oral Thiamine
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Baystate Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
Elevated levels of thiamine may increase cellular energy metabolism by increasing the activity of pyruvate dehydrogenase complex. This has been hypothesized to have a beneficial affect in patients with several diseases including sepsis, heart failure, and diabetes. There is limited data on the pharmacokinetics of supraphysiologic doses of oral thiamine. The aims of this study are to: * Calculate the plasma and whole blood pharmacokinetics of supraphysiologic doses of oral thiamine in healthy volunteers; * Compare the different thiamine doses on the pharmacokinetic variables using repeated measures ANOVA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Thiamine | Vitamin B1 |
| DIETARY_SUPPLEMENT | Placebo | Placebo |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2010-07-01
- Completion
- 2010-07-01
- First posted
- 2011-09-14
- Last updated
- 2011-09-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01433952. Inclusion in this directory is not an endorsement.